Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2010-01-22

Clinical Trial Update: A Study to Assess the Efficacy and Safety of Ganirelix (Orgalutran®) Treatment in Chinese Women Undergoing Controlled Ovarian Stimulation for in Vitro Fertilization (IVF) or Intra Cytoplasmatic Sperm Injection (ICSI) (Study 38651)(P05703) [Phase 3]

View source ↗

Summary

Phase 3 trial assessing ganirelix (Orgalutran) for controlled ovarian stimulation in Chinese women undergoing IVF/ICSI was completed with results posted in 2010…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ganirelix (ganirelix acetate)
  • Orgalutran (ganirelix)

Snippet

Sponsor: Organon and Co | Conditions: Controlled Ovarian Stimulation | Phase 3 | Status: COMPLETED | Results posted: 2010-01-22